Directory Profile

Kerry M. Empey, PharmD, PhD

Phone: 412-648-9629

Email: kme33@pitt.edu

orcidpubmedLinkedIn

Dr. Kerry Empey is an Associate Professor in the Department of Pharmacy and Therapeutics and Center for Clinical Pharmaceutical Sciences. She holds secondary appointments in the Clinical and Translational Science Institute and in the Department of Immunology at the University of Pittsburgh. As a clinician-scientist, Dr. Empey conducts NIH-funded clinical and translational research aimed at understanding critical immune targets involved in inefficient neonatal host immune responses to pulmonary infections with the primary goal of improving disease outcomes through immune modulating therapies.

She received her PharmD from the University of Rhode Island and completed PGY1 and PGY2 residencies in Pharmacy Practice and Infectious Diseases at the University of Kentucky. She earned a PhD in Clinical Pharmaceutical Sciences at the University of Kentucky before accepting a faculty position at the University of Pittsburgh. In her current role as Associate Professor in the School of Pharmacy, Dr. Empey chairs the Graduate Curriculum Committee and the PharmD Research ARCO (Area of concentration). She also coordinates Clinical Pharmacy Environments, a unique, hands-on experience designed to introduce pharmacy-based clinical research to graduate-level students. Within the PharmD curriculum, she teaches pharmacokinetics, pharmacodynamics, pharmacy and therapeutics and immunology.

The Empey Lab is interested in understanding the role of age-based factors that influence host immune responses to pulmonary infections that are prominent in infant and childhood populations. Specifically, Dr. Empey's lab studies how age-dependent immune factors influence early life viral pulmonary infections as well as direct and maternal immunization strategies. The Empey Lab also evaluates immune modulating strategies to improve immune responses to viral infections such as respiratory syncytial virus (RSV). RSV is a pulmonary virus that infects the very young, the elderly, and the immune compromised. Children that develop severe RSV disease at a young age have a higher risk for developing allergic asthma. Thus Dr. Empey's lab is also interested in understanding the immune mechanisms associated with RSV-associated asthma and identifying immune targets to mitigate this risk. Dr. Empey works with several small companies in testing the safety and efficacy of vaccine candidates in their novel infant mouse model of respiratory syncytial virus (RSV) infection and has several patent applications in this space. In addition to their small animal work, Dr. Empey works with pediatricians at the Children's Hospital of Pittsburgh to translate their findings in mice to human children to better understand cellular responses to viruses and treatments using ex vivo models. Dr. Empey's lab uses a variety of tools to address these important research questions, including computational approaches. This strategy is critical to assess the network of immune pathways that respond to viruses and treatments. Taken together, the Empey lab uses multiple approaches to address clinically important research question related to childhood responses to pulmonary viruses.

1. Empey KM. The Facts on Antibiotic Conversion Therapy. JAAPA. 2001 Nov;14(11): 40
2. Rapp RP, Empey KM. Editorial: Antimicrobial Cycling. Annals of Pharmacotherapy. 2001 Oct;35(10): 1289-90. PMID: PMID:11675862
3. Empey KM, Rapp RP, Evans ME. The Effect of an Antimicrobial Formulary Change on Resistance Patterns at a University Hospital. Pharmacotherapy. 2002 Jan;22(1):81-7.
PMID: PMID: 11794434
4. Romanelli F, Empey KM, Pomeroy C. Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection. AIDS Patient Care and STDs. 2002 Sep;16(9):405-11. PMID: PMID12396692
5. Rapp RP, Evans M, Martin C, Ofotokun I, Empey K, Armitstead JA. Drug Costs and Bacterial Susceptibility After Implementing A Single-Fluoroquinolone Use Policy at A University Hospital. Current Medical Research and Opinion. 2004 Apr;20(4):469-476. PMID: PMID15119984
6. Empey KM, Hollifield M, Schuer K, Gigliotti F, Garvy BA. Passive Immunization of Neonatal Mice Against Pneumocystis carinii f. sp. muris Enhances Control of Infection Without Stimulating Inflammation. Infection and Immunity. 2004 Nov;72(11):6211-6220. PMID: PMID15501746; PMCID: PMC523030
7. Qureshi MH, Empey KM, Garvy BA. Modulation of Pro-inflammatory Responses to Pneumocystis carinii f. sp. muris in Neonatal Mice by GM-CSF and IL-4: Role of Antigen Presenting Cells. Journal of Immunology. 2005 Jan 1;174(1):441-8. PMID: PMID15611269
8. Martin C, Ofotokun I, Rapp R, Empey K, Armitstead J, Pomeroy C, Hoven A, Evans M. Results of an Antimicrobial Control Program at a University Hospital. AJHP 2005 Apr 62(7):732-8. PMID:15790801
9. Empey KM, Hollifield M, Garvy BA. Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice. Infection and Immunity. 2007 Jul;75(7):3382-93. PMID: ID17485459; PMCID: PMC1932967
10. Empey KM, RS Peebles, JK Kolls. Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. Clin Infect Dis. 2010 50(9), 1258-1267. PMID: PMID20235830; PMCID: PMC2851489
11. Poloyac SM, Empey KM, Rohan LC, Skledar SJ, Empey PE, Nolin TD, Bies RR, Gibbs RB, Folan M, Kroboth PD. Core Competencies for Research Training in the Clinical Pharmaceutical Sciences at the University of Pittsburgh School of Pharmacy. Am J Pharm Ed. 2011 Mar 10;75(2):27. PMID: PMID21519417; PMCID: PMC3073101
12. Kurkjian C, Hollifield M, Lines JL, Rogosky A, Empey KM, Qureshi M, Brown SA, and Garvy BA. Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis infection. Spotlight article. Infect and Immun. 2012 Aug;80(80):2835-46
13. Empey KM, Orend JG†, Peebles RS, Jr., Norris KA, Oury TD, and Kolls JK. Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus. PLoS One. Epub 2012 Jul 7(7):e40499. PMID: PMID22792355; PMCID: PMC3391240
14. Smith MA#, Hibino M#, Falcione B, Eichinger KM#, Patel R#, Empey KM. Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patients. Annals Pharmacother. 2014 Jan;48(1):77-85. PMID: PMID24259637; PMCID: PMC4052449
15. Kling HM, Nau GJ, Ross TM, Evans TM, Chakraborty K, Empey KM, Flynn JL. Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy: Proceedings from the 2013 Pittsburgh Lung Conference. Annals of the Am Thoracic Soc. 2014 Aug;11(Suppl 4):S201-S210. PMID: PMID25148426; PMCID: PMC4200570
16. Eichinger KM#, Egaña L†, Orend JG†, Resetar E#, Patel R#, Empey KM. Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice. Respir Research. 2015 Oct;16:122. PMID: PMID26438053; PMCID: PMC4594958
17. Hendricks MR, Lashua LP, Fischer DK, Flitter BA, Eichinger KM#, Durbin JE, Sarker SN, Coyne CB, Empey KM, Bomberger JM. Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity. PNAS. 2016 Feb;113(6):1642-7. PMID: PMID26729873; PMCID: PMC4760822
18. Eichinger KM#, Resetar E#, Orend J†, Anderson K, Empey KM. Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFNγ and GM-CSF in a mouse model of RSV infection. Cytokine. 2017 May;97:25-37. PMID: PMID28558308; PMCID: PMC5541950
19. Gong T, Zhang W, Parniak MA, Graebing PW, Moncla B, Gupta P, Empey KM, Rohan LC. Preformulation and Vaginal Film Formulation Development of Microbicide Drug Candidate CSIC for HIV Prevention. J pharmaceutical innovation. 2017 June 01; 12(2):142-154.PMID: PMID28983328; PMCID: PMC5624728
20. Eichinger KM# and Empey KM. Data describing IFNγ-mediated clearance in an adult mouse model of respiratory syncytial virus (RSV). Elsevier Data-in-Brief. 2017 July 19; 14:272-277. PMID: PMID28861450; PMCID: PMC5567392
21. Eichinger KM#, Kosanovich JL†, Empey KM. Localization of an anti-viral T cell response to RSV infection is altered in infant mice. Pediat. Pulmonology. 2018; 53:145-153.
PMID: PMID29115050; PMCID: PMC5775046
22. Prefusion RSV F immunization elicits Th2-mediated lung pathology in mice when formulated with a Th2) but not a Th1/Th2-balanced) adjuvant despite complete viral protection. Front Immunol. Eichinger KM#, Kosanovich JL†, Gidwani SV, Zomback A, Lipp MA, Perkins TN, Oury TD, Petrovsky N, Marshall CP, Yondola MA, Empey KM. Front. Immunol. 2020 July 29; 11:1673. PMID: 32849580
23. Formulation of the prefusion RSV F protein with a Th1/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young mice. Vaccine. Kosanovich JK†, Eichinger KM#, Lipp MA#, Yondola MA, Perkins TN, Empey KM. 2020, Sep 22;38(31):6357-6362. PMID: 32829976
24. Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity. Vaccine. Eichinger KM#, Kosanovich JL†, Lipp MA#, Perkins TN, Petrovsky NP, Marshall CP, Yondola MA, Empey KM. 2020, Nov 25; 38(50):7885-7891. PMID:33129608
25. McGarr KL. Treatments for Cough and Cold Symptoms: Patient Information. Harvard Pilgrim Health Center Patient Pamphlet. Sept/Oct 1998
26. McGarr KL, Benson-Sardo P. Decreasing Antibiotic Prescriptions for Viral Infections and Decreasing Bacterial Resistance. Harvard Pilgrim Health Center Newsletter. Sept/Oct 1998
27. McGarr KL, Robinson C. Co-editor Kentucky Konnection, Annual Pharmacy Practice Residency Newsletter: 1999 and 2000
28. Empey KM. Ketamine (Ketalar®) Sedation monograph production and design for use within the deep sedation guidelines at the University of Kentucky Chandler Medical Center, Lexington, KY. 2000
29. Empey KM. Methohexital (Brevitol®) Sedation monograph production and design for use within the deep sedation guidelines at the University of Kentucky Chandler Medical Center, Lexington, KY. 2000
30. Empey KM. Propofol (Diprivan®) Sedation monograph production and design for use within the deep sedation guidelines at the University of Kentucky Chandler Medical Center, Lexington, KY. 2000
31. Empey KM, Peebles RS, Kolls JK. Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus. Clin Infect Dis. 2010 May 1; 50(9):1258-67.
PMID: PMID20235830; PMCID: PMC2851489
32. Empey KM and Kolls JK. Neonatal Pulmonary Host Defense Mechanisms. In: Fetal and Neonatal Physiology, 4th Ed. Chapter 159, p 1701. Elsevier Ed. By Polin, Fox, Abman. 2011
33. Good M, Kolls JK, Empey KM. Neonatal Pulmonary Host Defense Mechanisms. In: Fetal & Neonatal Physiology, 5th Ed. Chap 130, Elsevier Ed. By Polin, Fox, Abman. July 15, 2016
34. Empey KM, Janssen WJ, Peebles RS. Lung Innate Immunity and Inflammation: Mouse Models of Viral Infection. In: Methods & Protocols. Springer Ed. By Alper & Janssen. 2018
35. Strategies for active and passive pediatric RSV immunization. Ther Adv Vaccines Immunother. Eichinger KM, Kosanovich JK, Lipp M, Empey KM, Petrovsky N. 2021, Feb 10; 9:1-21.

2001 Wyeth-Ayerst Infectious Disease Fellow
2001-2006 Research Challenge Trust Foundation Fellowship
2004-2006 AFPE Pharmaceutical Sciences Graduate Student Recognition Award
2013 Clinical Research Scholars Program – Graduate, High Distinction
2013 David and Betty Brenneman Scholar Award
2017 AFPE Gateway to Research Award, on behalf of research student
2017 AAI Travel award, on behalf of graduate student
2017 PLOS One top 25% most cited manuscript
2019 Selected for the Women in Academic Leadership (WIN-AL) Program

1. Empey KM, Rapp RP. Antibiotic resistance patterns before and after formulary restriction of third generation cephalosporins. American College of Clinical Pharmacy, Salt Lake City, UT, April 2001.
Published in: Pharmacotherapy; 21(3), 148.
2. Empey KM, Hollifield M, Garvy BA. The Response of Neonatal Alveolar Macrophages (AMs) to Pneumocystis in the Presence of Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF), San Diego, CA, 2005. Published in: FASEB Journal; A936
3. Empey KM. Local immunomodulation with inhaled cytokines as a novel therapy for respiratory Syncytial virus in infants. National Annual Meeting for CTSA KL2, K12, and K30 Clinical Research Scholars, NIH National Center for Research Resources and Association for Clinical Research Training (ACRT): Washington, D.C., 2008.
4. Empey KM, Rapp RP. Antibiotic resistance patterns before and after formulary restriction of third generation cephalosporins. American College of Clinical Pharmacy, Salt Lake City, UT, April 2001. Published in: Pharmacotherapy; 21(3), 148.
5. Empey KM, Hollifield M, Garvy BA. The Response of Neonatal Alveolar Macrophages (AMs) to Pneumocystis in the Presence of Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF), San Diego, CA, 2005. Published in: FASEB Journal; A936
6. Empey KM, Rapp RP. Antibiotic resistance patterns before and after formulary restriction of third generation cephalosporins. American College of Clinical Pharmacy, Salt Lake City, UT, April 2001. Published in: Pharmacotherapy; 21(3), 148.
7. Empey KM, Hollifield M, Garvy BA. The Response of Neonatal Alveolar Macrophages (AMs) to Pneumocystis in the Presence of Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF), San Diego, CA, 2005. Published in: FASEB Journal; A936
8. Empey KM, Rapp RP. Antibiotic resistance patterns before and after formulary restriction of third generation cephalosporins. American College of Clinical Pharmacy, Salt Lake City, UT, April 2001. Published in: Pharmacotherapy; 21(3), 148.
9. Empey KM, Hollifield M, Garvy BA. The Response of Neonatal Alveolar Macrophages (AMs) to Pneumocystis in the Presence of Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF), San Diego, CA, 2005. Published in: FASEB Journal; A936
10. Empey KM. Local immunomodulation with inhaled cytokines as a novel therapy for respiratory Syncytial virus in infants. National Annual Meeting for CTSA KL2, K12, and K30 Clinical Research Scholars, NIH National Center for Research Resources and Association for Clinical Research Training (ACRT): Washington, D.C., 2008.
11. Empey KM, Peebles RP, Kolls JK. Local Immunomodulation with Inhaled Cytokines as a Novel Therapy for Respiratory Syncytial Virus (RSV) in Infants. ACRT/SCTS Joint Annual Meeting, Washington DC, 2010.
12. Kar I#, Orend J†, Empey KM. Comparing Plaque Assays for Viral Quantification to Study RSV Pathogenesis. Duquesne University Graduate Research, Pittsburgh, PA, 2010.
13. Kar I#, Orend J†, Empey KM. Comparing Plaque Assays for Viral Quantification to Study RSV Pathogenesis. Pittsburgh School of Pharmacy GEAR-UP, Pittsburgh, PA, 2010.
14. Patel R#, Orend J†, Empey KM. Effect of age at initial RSV infection on lung macrophage phenotype. Pittsburgh School of Pharmacy GEAR-UP, Pittsburgh, PA, 2011.
15. Orend J†, Patel R#, Empey KM. Effect of age at initial RSV infection on lung macrophage phenotype. Duquesne University Graduate Research, Pittsburgh, PA, 2011.
16. Patel R#, Orend J†, Empey KM. Effect of age at initial RSV infection on lung macrophage phenotype. University of Pittsburgh Science, Pittsburgh, PA, 2011.
17. Kar I#, Orend J†, Empey KM. Do differences among quantitative viral plaque assays explain variability among pre-clinical respiratory syncytial virus studies in animals? American Colleges of Clinical Pharmacy, Pittsburgh, PA, October 2011. Published in: Pharmacotherapy; 31(10)311e-453e.
18. Eichinger K#, Resetar E#, Empey KM. Airway Immune Response and Systemic Exposure of Inhaled rGM-CSF in Infant Mice. University of Pittsburgh Science, Pittsburgh, PA, 2012.
19. Empey KM. Overcoming an Immature Situation: Immunotherapy in a Neonatal Mouse Model of RSV Infection. University of Pittsburgh, Division of Pulmonary, Allergy and Critical Care Medicine, Pittsburgh, PA, 2012.
20. Eichinger K#, Resetar E#, Empey K. Age related pharmacokinetic and dynamic differences in response to intranasal IFN. University of Pittsburgh Science, Pittsburgh, PA, 2012.
21. Eichinger KM#, Resetar E#, Empey K. Pharmacokinetic and pharmacodynamic response to intranasal IFNγ: pups vs. adults. Autumn Immunology Conference, Chicago, IL, 2012.
22. Resetar E#, Eichinger K#, Empey K. Pharmacokinetics and pharmacodynamics of inhaled rGM-CSF in infant mice. Autumn Immunology Conference, Chicago, IL, 2012.
23. Empey KM, Ross TM, Clancy NJ, Kolls JK. Inhaled Cytokines as a Novel Therapy for Respiratory Syncytial Virus in Infants. Association for Clinical and Translational Science, Washington, DC, 2012.
24. Resetar E#, Eichinger K#, Anderson K, and Empey K. Age related pharmacokinetic and pharmacodynamics response of intranasal rGM-CSF. American Association of Immunologists, Honolulu, HI, 2013. Published in: J Immunol;190 (1 Supp), 48.5, 2013.
25. Empey K. Understanding the role of IFN in an infant mouse model of respiratory syncytial virus (RSV). Pittsburgh International Lung Conference, Pittsburgh, PA, 2013
Published in: Ann Am Thorac Soc; 11, (Supp 4), S201-S210.
26. Eichinger K#, Alcorn J, Resetar E#, Egana L†, Empey K. Understanding the role of IFN in an infant mouse model of respiratory syncytial virus (RSV). Pittsburgh Lung Conference, Pittsburgh PA, 2013.
27. Eichinger K#, Resetar E#, Egana L†, Alcorn J, Empey K. Inhaled interferon γ (IFNγ) during primary respiratory Syncytial Virus (RSV) infection induces airway hyperresponsiveness (AHR) after RSV re-challenge. Autumn Immunology Conference, Chicago, IL, 2014.
28. Lichvar AB, McDyer JF, Pilewski JM, Empey KM, Ensor CR. Oral Ribavirin for the treatment of Paramyxovirus respiratory infections in lung transplant patients. American Colleges of Clinical Pharmacy, San Diego, CA, 2015. Published in: Pharmacotherapy; 10; E228-E228, 197
29. Hendricks MR, Lashua LP, Fischer DK, Flitter BA, Eichinger KM#, Durbin JE, Sarker SN, Coyne CB, Empey KM, Bomberger JM. Respiratory virus co-infection induces iron secretion to enhance Pseudomonas aeruginosa biofilm growth on airway epithelial cells. American Thoracic Society of America, Denver, CO, 2015. Published in: Am J Respir Crit Care Med; 191, A3948.
30. Eichinger K#, Detanico L#, Kosanovich J†, and Empey K. Macrophages are critical coordinators of the infant immune response to respiratory syncytial virus (RSV) disease. Poster presentation. Autumn Immunology Conference, Chicago, IL, 2015.
31. Eichinger K#, Kosanovich J†, Detanico L#, Empey K. Macrophages critically regulate the infant immune response to respiratory syncytial virus (RSV) infection. Immunology/Microbiology & Molecular Genetics Retreat, Pittsburgh, PA, 2016.
32. Eichinger K#, Kosanovich J†, Manni M, Alcorn J, and Empey K. Immunomodulation during primary neonatal RSV infection alters memory response. Pittsburgh-Munich Lung Conference, Pittsburgh, PA, 2016.
33. Eichinger K#. Kosanovich J†, Gillespie D, Jackson E, and Empey K. Extracellular adenosine in the airway significantly contributes to the blunted neonatal immune response to respiratory syncytial virus. Department of Immunology Retreat, Oglebay, WV, 2016.
34. Patel A, Kosanovich J†, Balmuri S, Krishnan H, Empey K, Sant S. Free radical modulating nanoparticles induce innate immune response. Society for Biomaterials, Minneapolis, MN, 2017.
35. McCann M#, Kosanovich J†, Eichinger K#, Tchen S#, Poloyac S, and Empey K. Interferon gamma Treatment Increases Prostaglandin Levels in Neonatal Mice. Autumn Immunology Conference Chicago, IL, 2016.
36. Eichinger K#, Kosanovich J†, and Empey K. Remembering RSV: The role of alveolar macrophages. Autumn Immunology Conference, Chicago, IL, 2016.
37. Kosanovich J†, Eichinger K#, and Empey K. Generation of RSV-specific CD8+ T cells in neonatal mice following IFNγ treatment. Autumn Immunology Conference, Chicago, IL, 2016.
38. Patel A, Kosanovich J†, Balmuri S, Krishnan H, Empey K, Sant S. Free radical modulating nanoparticles induce innate immune response. Poster presentation. Pitt-Pharmacy Graduate Program Research Retreat, Pittsburgh, PA, 2017.
39. Eichinger K# and Empey K. Investigating the role of adenosine in infant RSV. University of Pittsburgh Department of Immunology Research in Progress, Pittsburgh, PA, 2017.
40. Sridharan M#, Tsai Y#, Deslouches B, Di P, Empey K. SPLUNC as a potential anti-viral agent against respiratory syncytial virus (RSV). Pitt-Pharmacy Graduate Program Research Retreat, Pittsburgh, PA, 2017.
41. Eichinger KM#, Kosanovich J†, Manni ML, Alcorn JF, Empey KM. Immunostimulation during primary neonatal RSV infection alters memory response. Pitt-Pharmacy Graduate Program Research Retreat, Pittsburgh, PA, 2017.
42. Eichinger KM#, Kosanovich J†, Manni ML, Alcorn JF, Empey KM. Immunostimulation during primary neonatal RSV infection alters memory response. American Association of Immunologists, Pittsburgh, PA, 2016.
Published in: J Immunol 198 (1 Supplement), 203.1, 2017.
43. McCann M#, Kosanovich J†, Eichinger K#, Tchen S#, Poloyac S, and Empey K. Interferon gamma treatment increases prostaglandin levels in neonatal mice. Pitt-Pharmacy Graduate Program Research Retreat, Pittsburgh, PA, 2017.
44. Empey KM, Petrovsky N, Marshall C. Maternal Vaccine for RSV in Infants ID:4429. Bio International Conference, Boston, MA, 2018
45. Tsai Y, Sridharan M, Weaver D, Kosanovich J, Eichinger K, Empey K, Deslouches B, Di P. Novel AMPs against Respiratory Syncytial Virus. Autumn Immunology Conference, Chicago, IL, 2018.
46. Eichinger K, Kosanovich J, Petrovsky N, Empey K. Maternal RSV pre-F + Advax-SM immunization elicits balanced T helper sterilizing immunity to RSV in mothers and offspring without inducing lung pathology. Autumn Immunology Conference, Chicago, IL, 2018.
47. Empey KM. Preparing graduate students for clinical research in the pharmaceutical sciences. Assessment and Teaching Conference. Pittsburgh, PA, 2021

5T32AI089443-11 (Trainee: Lipp*/ Mentor: Empey)
Title: Effect of age on tissue resident memory T cell establishment in the respiratory tract following RSV infection
Source: National Institute of Allergy and Infectious Diseases, NIH
Autoimmunity and Immunopathology Training Program (PI: Shlomchik)

R01HL142587 (PI:Bomberger)
Title: Polymicrobial interactions in the respiratory tract.
Source: NHLBI, NIH

R43AI140941 – Phase I (PI:Empey/Yondola – Calder Biosciences)
Title: An adjuvant for an RSV prefusion F vaccine that safely protects infants via maternal vaccination
Source: National Institute of Allergy and Infectious Diseases, National Institutes of Health

UL1 TR001857 - TL1 Postdoctoral Scholar (Scholar: Eichinger*/ Mentor: Empey)
Title: Investigating maternal RSV vaccination as a mechanism to prevent acute RSV in infants and protect from long-term sequelae
Source: NCATS, NIH, U. of Pittsburgh Clinical & Translational Science Fellowship (PI: Reis)

Project: Pitt SEED Grant (PI: Empey)
Title: Pitt Participation in the Student Spaceflight Experiments Program
Source: University of Pittsburgh, Office of the Provost

David and Betty Brenneman Fund (PI: Empey)
Title: Making Medicines Work for People
Source: University of Pittsburgh, School of Pharmacy

AFPE Gateway to Research Award (Student: McCann*/ Mentor: Empey)
Title: Maternal Vaccination with DS-Cav1/Advax-SM
Source: American Foundation for Pharmaceutical Education

Mentored Research Fellowship (Student PI: Tsai*/Mentor: Empey)
Source: Student College of Clinical Pharmacy, Student chapter of the American College of Clinical Pharmacy

5T32AI089443-07 (Trainee: Eichinger*/ Mentor: Empey)
Title: The role of extracellular adenosine in modulating the infant immune response to respiratory syncytial virus (RSV)
Source: National Institute of Allergy and Infectious Diseases, NIH
Autoimmunity and Immunopathology Training Program (PI: Shlomchik)

R03-RHD080874A (PI:Empey)
Title: Immature infant alveolar macrophage clearance of cell debris during RSV infection
Source: National Institute of Child Health and Human Development, NIH

Central Medical Research Fund University of Pittsburgh (PI:Empey).
Title: A novel approach to treating infant respiratory syncytial virus (RSV) disease: therapeutic stimulation of immature alveolar macrophages to enhance anti-viral activity
Source: Office of Research, University of Pittsburgh

Central Research Development Fund (PI: Empey)
Title: Development of an RSV-infected infant mouse model
Source: University of Pittsburgh, Office of Research

KL2 RR024154 (PI: Empey/Reis)
Title: Intranasal delivery of IFNγ in a neonatal mouse model of infant RSV disease
Source: National Center for Advancing Translational Sciences, NIH
U Pittsburgh Clinical and Translational Science Institute

Endowed Pre-doctoral Fellowship (PI: Empey)
Title: Response of Neonatal Alveolar Macrophages to Immunostimulation and Clearance of Pneumocystis Infection
Source: American Foundation for Pharmaceutical Education

K30 HL004163 (Scholar PI: Empey/Pomeroy)
Title: Immunomodulation to Improve Pneumocystis Clearance in Neonatal Mice
Source: NCRR, NIH Career Training in Therapeutics & Translational Research